user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 438907 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

Antares Pharma Ranks the Highest in Terms of Revenue Per Employee in the Health Care Supplies Industry (AIS, VIVO, CERS)

Published on Fri, 02/08/2013 - 11:18
By Peter Chu

Below are the three companies in the Health Care Supplies industry with the highest Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the productivity of companies in the same industry.

Antares Pharma (AMEX:AIS) is highest with an RPE of $1.1 million. Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Potential upside of 61.6% exists for Antares Pharma, based on a current level of $3.30 and analysts' average consensus price target of $5.33. The stock should find initial support at its 50-day moving average (MA) of $3.04 and further support at its 200-day MA of $2.60.

Meridian Bioscience (NASDAQ:VIVO) is next with an RPE of $629,000.

Finishing up the top three is Cerus (NASDAQ:CERS), with an RPE of $464,000.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

TD Securities Made the Right Call, Pan A...

Pan American Silver was downgraded from Buy to Hold by TD Securities one week ago. The ...

Analyst Rating In Review: Medivation Bid...

One week ago Medivation (NASDAQ:MDVN) was downgraded from Buy to Neutral at Goldman Sac ...

Auxilium Pharmaceuticals In Retrospect: ...

RBC Capital downgraded Auxilium Pharmaceuticals (NASDAQ:AUXL) from Outperform to Sector ...

Analyst Rating In Review: Marvell Techno...

A week ago, JMP Securities upgraded Marvell Technology from Underperform to Market Perf ...

Buffalo Wild Wings Fulfills the Promise:...

A week ago, Miller Tabak upgraded Buffalo Wild Wings from Hold to Buy. Buffalo Wild Wi ...

Ericsson Down 1.6% Since UBS Downgraded ...

UBS downgraded Ericsson (NASDAQ:ERIC) from Buy to Neutral a week ago. The shares close ...

Analyst Rating Flashback: SYNNEX Up 8.1%...

Raymond James upgraded SYNNEX (NYSE:SNX) from Market Perform to Outperform a week ago. ...

Freeport-McMoRan In Retrospect: Shares D...

A week ago, Tigress Financial downgraded Freeport-McMoRan from Strong Buy to Neutral. ...